News

Recursion Pharmaceuticals is laying off a fifth of its workforce in connection with a previously announced streamlining of ...
A very different prediction comes by way of Chris Gibson, the CEO of AI-powered biotech Recursion ... to work on, it begins with cells instead. Recursion then studies those cells using imaging ...
Recursion then takes a microscopic snapshot of the reaction and uses machine-learning software trained to spot the sick and healthy cells to sort out what works. “It lets you operate without ...